You have 9 free searches left this month | for more free features.

Sarcoma, Clear Cell

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Clear Cell Sarcoma of Soft Tissue Trial in Wuhan (18F-PFPN)

Recruiting
  • Clear Cell Sarcoma of Soft Tissue
  • Wuhan, Hubei, China
    China, Hubei Province
Jul 19, 2023

Clear Cell Sarcoma Trial in El Segundo, Houston (AMG 337)

Terminated
  • Clear Cell Sarcoma
  • AMG 337
  • El Segundo, California
  • +1 more
Dec 9, 2022

Sarcoma, Clear Cell Trial in United States (CPI-613 + Hydroxychloroquine)

Recruiting
  • Sarcoma, Clear Cell
  • CPI-613 + Hydroxychloroquine
  • Duarte, California
  • +7 more
Nov 10, 2022

Sarcoma, Clear Cell Trial in Lyon, Milan, Sevilla (TSR-042)

Recruiting
  • Sarcoma, Clear Cell
  • Lyon, France
  • +2 more
Oct 29, 2021

Soft Tissue Sarcoma, Clear Cell Sarcoma, Epithelioid Sarcoma Trial in France (Patient with Soft Tissue Sarcoma)

Recruiting
  • Soft Tissue Sarcoma
  • +9 more
  • Patient with Soft Tissue Sarcoma
  • Besancon, France
  • +13 more
Oct 11, 2022

Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)

Recruiting
  • Pediatric Solid Tumor
  • +15 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jun 30, 2022

Ewing Sarcoma, Myxoid Liposarcoma, Desmoplastic Small Round Cell Tumor Trial in Santa Monica (Seclidemstat)

Enrolling by invitation
  • Ewing Sarcoma
  • +8 more
  • Santa Monica, California
    Sarcoma Oncology Center
Feb 23, 2022

Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

Recruiting
  • Pediatric Solid Tumor
  • +15 more
  • second generation 4-1BBζ EGFR806-EGFRt
  • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
  • Seattle, Washington
    Seattle Children's Hospital
May 2, 2022

Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer, Gastric Cancer Trial in New Haven (APG-5918)

Recruiting
  • Nasopharyngeal Carcinoma
  • +8 more
  • Springdale, Arkansas
    Highlands Oncology
Nov 11, 2022

Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Renal Cell Carcinoma Trial in Boston (GVAX)

Completed
  • Sarcoma, Clear Cell
  • +3 more
  • GVAX
  • Boston, Massachusetts
  • +1 more
Mar 2, 2021

Ewing Sarcoma, Myxoid Liposarcoma, Sarcoma,Soft Tissue Trial in United States (Seclidemstat, Cyclophosphamide, Topotecan)

Recruiting
  • Ewing Sarcoma
  • +10 more
  • Los Angeles, California
  • +16 more
Jan 18, 2022

Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma, Locally Advanced and/or Metastatic Inflammatory

Active, not recruiting
  • Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma
  • +5 more
  • Crizotinib (PF-02341066)
  • Brussels, Belgium
  • +24 more
May 9, 2022

Osteosarcoma, Bone Tumor, Bone Sarcoma Trial

Not yet recruiting
  • Osteosarcoma
  • +25 more
    • (no location specified)
    Aug 24, 2022

    Uterine Cancer, Endometrial Carcinoma, Carcinosarcoma Trial in United States (Nivolumab)

    Active, not recruiting
    • Uterine Cancer
    • +6 more
    • Basking Ridge, New Jersey
    • +7 more
    Apr 4, 2022

    Sarcoma, Alveolar Soft Part Sarcoma, Clear Cell Sarcoma Trial in Warsaw (Hypofractionated radiotherapy, Hyperthermia)

    Active, not recruiting
    • Sarcoma
    • +10 more
    • Hypofractionated radiotherapy
    • Hyperthermia
    • Warsaw, Mazovian, Poland
      Maria Sklodowska-Curie Institute - Oncology Center
    Jan 27, 2021

    Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Boston (Stereotactic Body Radiotherapy (SBRT))

    Terminated
    • Ewing Sarcoma
    • +10 more
    • Stereotactic Body Radiotherapy (SBRT)
    • Boston, Massachusetts
    • +2 more
    Apr 5, 2021

    MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

    Active, not recruiting
    • MSI-H Colorectal Cancer
    • +30 more
    • Badalona, Barcelona, Spain
    • +9 more
    Oct 24, 2022

    Ovarian Clear Cell Carcinoma Trial in Houston (Dostarlimab, LB-100)

    Not yet recruiting
    • Ovarian Clear Cell Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 26, 2023

    Moesin Expression in Clear Cell Renal Cell Carcinoma

    Completed
    • Renal Cell Carcinoma
    • Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
    • (no location specified)
    Sep 20, 2023

    Ewing's Sarcoma, Osteosarcoma, Astrocytoma Trial in Atlanta (sirolimus)

    Completed
    • Ewing's Sarcoma
    • +15 more
    • Atlanta, Georgia
      Children's Healthcare of Atlanta
    May 27, 2020

    Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 18, 2023

    Ovarian Clear Cell Carcinoma Trial (Zimberelimab, Metformin Hydrochloride)

    Not yet recruiting
    • Ovarian Clear Cell Carcinoma
    • (no location specified)
    Feb 25, 2023

    Metastatic Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Metastatic Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 18, 2023

    Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,

    Active, not recruiting
    • Adrenal Cortex Carcinoma
    • +39 more
    • Birmingham, Alabama
    • +142 more
    May 24, 2022

    Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

    Recruiting
    • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
    • AK104(anti-PD-1/CTLA-4 bi-specific antibody ,intravenously),lenvatinib( targeted VEGFR 1-3、FGFR、PDGFRα, small molecule TKI,orally
    • Shanghai, Shanghai, China
      Shanghai Renji Hospital
    Sep 12, 2023